Modeling how pre-existing TCR clones affect vaccine-induced T-cell responses

The project aims to develop a computational tool to predict vaccine-induced immune responses by analyzing T-cell receptor repertoires before and after vaccination.

Subsidie
€ 150.000
2023

Projectdetails

Introduction

T-cells are increasingly recognized to be pivotal actors in the development of vaccine-induced immune responses. Through their T-cell receptor (TCR) on their cell surface, T-cells can recognize antigens derived from pathogens or vaccines. The strength of the interaction between the TCRs and the vaccine antigens will direct the T-cell dynamics after vaccination.

Project Overview

In this project, we will analyze the TCR repertoires from participants from three distinct vaccination cohorts prior to vaccination and after vaccination.

Computational Tool Development

We will develop a computational tool (later to be transformed into a software package) that will allow us to accurately predict, by using the baseline TCR data alone, which vaccinees will develop a robust immune response after vaccination.

Potential Impact

This tool holds the potential to have an important impact on different aspects and actors of vaccinology, ranging from the vaccine industry to public health researchers.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-12-2023
Einddatum31-5-2025
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • UNIVERSITEIT ANTWERPENpenvoerder

Land(en)

Belgium

Vergelijkbare projecten binnen European Research Council

ERC Proof of...

Computational scanning for responding clonotypes in immune repertoires

RESPOND is a user-friendly platform that integrates various algorithms to efficiently identify immune clonotypes for targeted vaccine and therapeutic development, reducing costs and time in drug discovery.

€ 150.000
ERC Starting...

Polyclonal anti-tumor immunity by engineered human T cells

This project aims to enhance adoptive T cell therapies for solid tumors by engineering TCR sensitivity and safety, creating robust, antigen-agnostic immune responses to improve patient outcomes.

€ 1.812.500
ERC Proof of...

Diagnostic model and assay for personalized vaccine

This project aims to develop a diagnostic assay to predict influenza vaccine responsiveness in immunocompromised patients using identified biomarkers and machine learning models, enhancing personalized vaccination strategies.

€ 150.000
ERC Consolid...

Molecular mimicry as a key parameter shaping T cell immunity

The MIMIC project aims to explore molecular mimicry's role in T cell recognition to enhance cancer immunotherapy by optimizing antigen selection based on pre-existing immunity insights.

€ 2.000.000
ERC Consolid...

Activation and switch of fates in T lymphocytes.

This project aims to model the fate choices of naïve and memory CD8+ T cells using experimental immunology and systems biology to enhance vaccine design and improve responses to infections and cancer.

€ 2.625.000

Vergelijkbare projecten uit andere regelingen

Mkb-innovati...

From A to BCR: B-Cell Receptor Repertoire Profiling for Antibody Development

Dit project ontwikkelt een geïntegreerde B-cel repertoire sequentiëringstechnologie om sneller en beter antilichamen te identificeren voor nieuwe geneesmiddelen en therapieën tegen kanker.

€ 153.020